These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hereditary angioedema--therapies old and new. Morgan BP N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894 [No Abstract] [Full Text] [Related]
4. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches]. Stehlin F; Ribi C Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933 [TBL] [Abstract][Full Text] [Related]
5. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema]. Leimgruber A Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938 [TBL] [Abstract][Full Text] [Related]
6. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report. Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States. Riedl MA; Banerji A; Manning ME; Burrell E; Joshi N; Patel D; Machnig T; Tai MH; Watson DJ Orphanet J Rare Dis; 2018 Oct; 13(1):180. PubMed ID: 30314518 [TBL] [Abstract][Full Text] [Related]
9. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886 [TBL] [Abstract][Full Text] [Related]
10. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema. Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974 [TBL] [Abstract][Full Text] [Related]
11. Current and emerging therapies to prevent hereditary angioedema attacks. Lumry WR Am J Manag Care; 2018 Aug; 24(14 Suppl):S299-S307. PubMed ID: 30132644 [TBL] [Abstract][Full Text] [Related]
12. [Several new treatment possibilities of hereditary angio-oedema]. Aabom AL; Palarasah Y; Bygum A Ugeskr Laeger; 2012 Aug; 174(34):1894-8. PubMed ID: 22909569 [TBL] [Abstract][Full Text] [Related]
13. An evidence based therapeutic approach to hereditary and acquired angioedema. Bork K Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294 [TBL] [Abstract][Full Text] [Related]
14. Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate. Gorman PJ Can Fam Physician; 2008 Mar; 54(3):365-6. PubMed ID: 18337530 [No Abstract] [Full Text] [Related]
15. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin]. Muller Y; Harr T Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort. Belbézier A; Boccon-Gibod I; Thanh AD; Fain O; Bouillet L; Ann Allergy Asthma Immunol; 2018 Oct; 121(4):506-508. PubMed ID: 29964227 [No Abstract] [Full Text] [Related]
17. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078 [TBL] [Abstract][Full Text] [Related]
18. Successful outcome using C1-inhibitor concentrate in acute pancreatitis caused by hereditary angioedema. Czaller I; Molnár K; Csuka D; Varga L; Farkas H Gastroenterol Nurs; 2011; 34(1):60-3. PubMed ID: 21301265 [No Abstract] [Full Text] [Related]
19. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema. Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742 [No Abstract] [Full Text] [Related]
20. Current treatment of hereditary angioedema: An update on clinical studies. Banerji A Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]